{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T09:35:56Z","timestamp":1794908156404,"version":"4.9.1"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Am Acad Orthop Surg","JAAOS"],"published-print":{"date-parts":[[2021,6,1]]},"abstract":"<jats:p>Dupuytren disease is a fibroproliferative disorder of the palmar fascia of the hand. Little agreement and remarkable variability exists in treatment algorithms between surgeons. Because the cellular and molecular etiology of Dupuytren has been elucidated, ongoing efforts have been made to identify potential chemotherapeutic targets that could modulate the phenotypic expression of the disease. Although these efforts may dramatically alter the approach to treating this disease in the future, these approaches are largely experimental at this point. Over the past decade, the mainstay nonsurgical options have continued to be percutaneous needle aponeurotomy and collagenase Clostridium hystoliticum, and the most common surgical option is limited fasciectomy.<\/jats:p>","DOI":"10.5435\/jaaos-d-20-00190","type":"journal-article","created":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T14:01:12Z","timestamp":1614693672000},"page":"462-469","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Current Concepts in the Management of Dupuytren Disease of the Hand"],"prefix":"10.5435","volume":"29","author":[{"given":"Joseph A.","family":"Gil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0778-5934","authenticated-orcid":false,"given":"Matthew R.","family":"Akelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Hresko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0234-5913","authenticated-orcid":false,"given":"Edward","family":"Akelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,3,2]]},"reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"746","DOI":"10.5435\/00124635-201112000-00005","article-title":"Dupuytren disease: An evolving understanding of an age-old disease","volume":"19","author":"Black","year":"2011","journal-title":"J Am Acad Orthop Surg"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.prs.0000438455.37604.0f","article-title":"A systematic review and meta-analysis on the prevalence of Dupuytren disease in the general population of Western countries","volume":"133","author":"Lanting","year":"2014","journal-title":"Plast Reconstr Surg"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s11552-008-9160-9","article-title":"Epidemiological evaluation of Dupuytren's disease incidence and prevalence rates in relation to etiology","volume":"4","author":"Hindocha","year":"2009","journal-title":"HAND"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11552-007-9076-9","article-title":"Gender ratio of Dupuytren's disease in the modern U.S. Population","volume":"3","author":"Anthony","year":"2008","journal-title":"HAND"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jhsa.2016.12.010","article-title":"The risk of Dupuytren surgery in obese individuals","volume":"42","author":"Hacquebord","year":"2017","journal-title":"J Hand Surg Am"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"367e","DOI":"10.1097\/PRS.0000000000004120","article-title":"A systematic review and meta-analysis on the strength and consistency of the associations between Dupuytren disease and diabetes mellitus, liver disease, and epilepsy","volume":"141","author":"Broekstra","year":"2018","journal-title":"Plast Reconstr Surg"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1471-2474-12-96","article-title":"Should we consider Dupuytren's contracture as work-related? A review and meta-analysis of an old debate","volume":"12","author":"Descatha","year":"2011","journal-title":"BMC Musculoskelet Disord"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/1753193410362848","article-title":"Re-visiting Luck's classification: A histological analysis of Dupuytren's disease","volume":"35","author":"Lam","year":"2010","journal-title":"J Hand Surg Eur Vol"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.hcl.2018.03.001","article-title":"The basic science of Dupuytren disease","volume":"34","author":"Zhang","year":"2018","journal-title":"Hand Clin"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"e0198326","DOI":"10.1371\/journal.pone.0198326","article-title":"Corticosteroid inhibits differentiation of palmar fibromatosis-derived stem cells (FSCs) through downregulation of transforming growth factor-\u03b21 (TGF-\u03b21)","volume":"13","author":"Wang","year":"2018","journal-title":"PLoS One"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ebiom.2018.06.022","article-title":"Anti-tumour necrosis factor therapy for Dupuytren's disease: A randomised dose response proof of concept phase 2a clinical trial","volume":"33","author":"Nanchahal","year":"2018","journal-title":"EBioMedicine"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/2000656X.2017.1319846","article-title":"Angiotensin receptors in Dupuytren's disease: A target for pharmacological treatment?","volume":"52","author":"Stephen","year":"2018","journal-title":"J Plast Surg Hand Surg"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"686e","DOI":"10.1097\/PRS.0000000000003800","article-title":"Effect of compound 21, a selective angiotensin II type 2 receptor agonist, in a murine xenograft model of Dupuytren disease","volume":"140","author":"Chisholm","year":"2017","journal-title":"Plast Reconstr Surg"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ajhg.2017.08.006","article-title":"A genome-wide association study of Dupuytren disease reveals 17 additional variants implicated in fibrosis","volume":"101","author":"Ng","year":"2017","journal-title":"Am J Hum Genet"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/PRS.0000000000005208","article-title":"A weighted genetic risk score predicts surgical recurrence independent of high-risk clinical features in Dupuytren's disease","volume":"143","author":"Riesmeijer","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2106\/00004623-195941040-00008","article-title":"Dupuytren's contracture; a new concept of the pathogenesis correlated with surgical management","volume":"41","author":"Luck","year":"1959","journal-title":"J Bone Joint Surg Am"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0749-0712(21)00447-9","article-title":"Dupuytren's disease of the radial side of the hand","volume":"15","author":"Tubiana","year":"1999","journal-title":"Hand Clin"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jhsa.2011.02.016","article-title":"Percutaneous fasciotomy for Dupuytren's contracture","volume":"36","author":"Eaton","year":"2011","journal-title":"J Hand Surg Am"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1097\/PRS.0000000000003357","article-title":"Early postoperative results of percutaneous needle fasciotomy in 451 patients with Dupuytren disease","volume":"139","author":"Molenkamp","year":"2017","journal-title":"Plast Reconstr Surg"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-0037-1605387","article-title":"Safety and effectiveness of percutaneous needle fasciotomy for Dupuytren's disease in the palm","volume":"09","author":"Mansha","year":"2017","journal-title":"J Hand Microsurg"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0266-7681(03)00013-5","article-title":"Percutaneous needle aponeurotomy: Complications and results","volume":"28 B","author":"Foucher","year":"2003","journal-title":"J Hand Surg Am"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2106\/JBJS.17.01128","article-title":"Percutaneous needle fasciotomy versus collagenase treatment for Dupuytren contracture","volume":"100","author":"Str\u00f6mberg","year":"2018","journal-title":"J Bone Joint Surg Am"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jhsa.2017.03.003","article-title":"Injectable collagenase versus percutaneous needle fasciotomy for Dupuytren contracture in proximal interphalangeal joints: A randomized controlled trial","volume":"42","author":"Skov","year":"2017","journal-title":"J Hand Surg Am"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1056\/NEJMoa0810866","article-title":"Injectable collagenase clostridium histolyticum for Dupuytren's contracture","volume":"361","author":"Hurst","year":"2009","journal-title":"N Engl J Med"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jhsa.2016.07.090","article-title":"The impact of collagenase clostridium histolyticum introduction on Dupuytren treatment patterns in the United States","volume":"41","author":"Zhao","year":"2016","journal-title":"J Hand Surg Am"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1001\/jamasurg.2016.3605","article-title":"Treatment of Dupuytren contracture with injectable collagenase within the veterans affairs system","volume":"152","author":"Duquette","year":"2017","journal-title":"JAMA Surg"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00264-017-3690-0","article-title":"Factors influencing recurrence and progression of Dupuytren's disease treated by collagenase clostridium histolitycum","volume":"42","author":"Sim\u00f3n-P\u00e9rez","year":"2018","journal-title":"Int Orthop"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"782e","DOI":"10.1097\/PRS.0000000000005443","article-title":"Collagenase clostridium histolyticum for Dupuytren's contracture: Comparing single and concurrent injections","volume":"143","author":"Cook","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jhsa.2017.02.010","article-title":"Treatment of recurrent Dupuytren contracture in joints previously effectively treated with collagenase clostridium histolyticum","volume":"42","author":"Bear","year":"2017","journal-title":"J Hand Surg Am"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jhsa.2019.07.017","article-title":"Outcomes and direct costs of needle aponeurotomy, collagenase injection, and fasciectomy in the treatment of Dupuytren contracture","volume":"44","author":"Leafblad","year":"2019","journal-title":"J Hand Surg Am"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1302\/0301-620X.100B1.BJJ-2017-0463.R1","article-title":"Efficacy and adverse effects of collagenase use in the treatment of Dupuytren's disease","volume":"100","author":"Sanjuan-Cerver\u00f3","year":"2018","journal-title":"Bone Joint J"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/1558944717711461","article-title":"Complications following collagenase treatment for Dupuytren contracture","volume":"12","author":"Wozniczka","year":"2017","journal-title":"Hand (N Y)"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12891-018-1949-2","article-title":"What do we know about managing Dupuytren's disease cost-effectively?","volume":"19","author":"Dritsaki","year":"2018","journal-title":"BMC Musculoskelet Disord"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1302\/0301-620X.95B8.31822","article-title":"Cost-effectiveness in the management of Dupuytren's contracture: A Canadian cost-utility analysis of current and future management strategies","volume":"95","author":"Baltzer","year":"2013","journal-title":"Bone Joint J"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"e2019861","DOI":"10.1001\/jamanetworkopen.2020.19861","article-title":"Cost-effectiveness of recurrent Dupuytren contracture treatment","volume":"3","author":"Yoon","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jhsa.2005.03.005","article-title":"A retrospective review of the management of Dupuytren's nodules","volume":"30","author":"Reilly","year":"2005","journal-title":"J Hand Surg Am"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.jhsa.2012.04.026","article-title":"Steroid injection and needle aponeurotomy for Dupuytren contracture: A randomized, controlled study","volume":"37","author":"McMillan","year":"2012","journal-title":"J Hand Surg Am"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1177\/1753193417695996","article-title":"Radiotherapy in Dupuytren's disease: A systematic review of the evidence","volume":"42","author":"Kadhum","year":"2017","journal-title":"J Hand Surg Eur Vol"},{"key":"R39-20250503","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.hcl.2018.03.010","article-title":"Advances in minimally invasive treatment of Dupuytren disease","volume":"34","author":"Hovius","year":"2018","journal-title":"Hand Clin"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.hcl.2018.03.007","article-title":"Complications of treatment for Dupuytren disease","volume":"34","author":"Eberlin","year":"2018","journal-title":"Hand Clin"},{"key":"R41-20250503","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1302\/0301-620X.100B9.BJJ-2017-1194.R2","article-title":"Treatment of Dupuytren's contracture","volume":"100","author":"Soreide","year":"2018","journal-title":"Bone Joint J"},{"key":"R42-20250503","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhsa.2013.04.012","article-title":"The effect of night extension orthoses following surgical release of Dupuytren contracture: A single-center, randomized, controlled trial","volume":"38","author":"Collis","year":"2013","journal-title":"J Hand Surg Am"},{"key":"R43-20250503","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1471-2474-12-136","article-title":"Night-time splinting after fasciectomy or dermo-fasciectomy for Dupuytren's contracture: A pragmatic, multi-centre, randomised controlled trial","volume":"12","author":"Jerosch-Herold","year":"2011","journal-title":"BMC Musculoskelet Disord"}],"container-title":["Journal of the American Academy of Orthopaedic Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-20-00190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:46:37Z","timestamp":1787669197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-20-00190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,2]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.5435\/jaaos-d-20-00190","relation":{},"ISSN":["1067-151X","1940-5480"],"issn-type":[{"value":"1067-151X","type":"print"},{"value":"1940-5480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,2]]},"assertion":[{"value":"2020-07-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}